The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2023

Filed:

Jul. 20, 2018
Applicant:

Korea University Research and Business Foundation, Seoul, KR;

Inventors:

Jae-Yong Park, Seoul, KR;

Eun Mi Hwang, Seoul, KR;

Heh-In Im, Seongnam-si, KR;

Chang-Hoon Cho, Seoul, KR;

Sangjoon Lee, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/027 (2006.01); A61K 49/00 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0276 (2013.01); A61K 49/0008 (2013.01); C07K 14/47 (2013.01); C07K 14/705 (2013.01); G01N 33/5088 (2013.01); G01N 33/6896 (2013.01); A01K 2217/054 (2013.01); A01K 2217/075 (2013.01); A01K 2217/206 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0318 (2013.01); A01K 2267/0356 (2013.01); G01N 2800/302 (2013.01);
Abstract

The present invention relates to: A schizophrenia animal model wherein the model is a mouse in which an anoctamin 1 (ANO1) gene is knocked out in cholinergic neurons of a medial habenula; and a preparation method therefor and the like. The schizophrenia animal model according to the present invention targets the medial habenula which is brain tissue playing a major role in the pathogenesis of schizophrenia, and it has been confirmed that when the ANO1 gene is specifically knocked out in the cholinergic neurons of the medial habenula, positive, negative and cognitive symptoms of schizophrenia are observed, thereby confirming that schizophrenia has been induced. Therefore, the animal model of the present invention is expected to be effectively useful in schizophrenia pathogenesis research and therapeutic agent development and screening.


Find Patent Forward Citations

Loading…